Morphic Holding Inc (MORF)
29.49
-0.92
(-3.03%)
USD |
NASDAQ |
May 21, 16:00
29.22
-0.27
(-0.92%)
Pre-Market: 20:00
Morphic Total Assets (Quarterly): 682.76M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 682.76M |
| December 31, 2023 | 722.51M |
| September 30, 2023 | 743.60M |
| June 30, 2023 | 748.72M |
| March 31, 2023 | 441.95M |
| December 31, 2022 | 368.59M |
| September 30, 2022 | 389.18M |
| June 30, 2022 | 413.88M |
| March 31, 2022 | 397.07M |
| December 31, 2021 | 426.29M |
| September 30, 2021 | 438.56M |
| Date | Value |
|---|---|
| June 30, 2021 | 439.48M |
| March 31, 2021 | 459.57M |
| December 31, 2020 | 242.38M |
| September 30, 2020 | 221.58M |
| June 30, 2020 | 212.00M |
| March 31, 2020 | 229.16M |
| December 31, 2019 | 247.44M |
| September 30, 2019 | 260.08M |
| June 30, 2019 | 178.61M |
| March 31, 2019 | 190.29M |
| December 31, 2018 | 189.30M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
178.61M
Minimum
Jun 2019
748.72M
Maximum
Jun 2023
413.17M
Average
405.47M
Median
Total Assets (Quarterly) Benchmarks
| Keros Therapeutics Inc | 485.82M |
| NovaBay Pharmaceuticals Inc | 5.357M |
| Palatin Technologies Inc | 11.41M |
| iBio Inc | 50.15M |
| Theriva Biologics Inc | 48.73M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 19.18M |
| Shareholders Equity (Quarterly) | 663.58M |